Isolation of Mouse Ig Heavy and Light Chain Genomic DNA Clones, and Construction of Gene Knockout Vector for the Generation of Humanized Xenomouse.
- Author:
Hee Kyung LEE
1
;
Sang Hoon CHA
Author Information
- Publication Type:Original Article
- Keywords: Hybridoma fusion; monoclonal antibody; human antibody; immunoglobulin gene; transgenesis; gene targeting
- MeSH: Animals; Antibodies; Antibodies, Monoclonal; Biotechnology; Brain; Clone Cells*; DNA*; Embryonic Stem Cells; Gene Knockout Techniques*; Gene Targeting; Gene Transfer Techniques; Genes, Immunoglobulin; Genetic Engineering; Genome; Genomic Library; Homologous Recombination; Human Body; Humans*; Hybridomas; Indicators and Reagents; Korea; Mass Screening; Mice*; Mice, Knockout; Mice, Transgenic; Polymerase Chain Reaction; Rodentia
- From:Immune Network 2002;2(4):233-241
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: Monoclonal antibodies (mAb) of rodent origin are produced with ease by hybridoma fusion technique, and have been successfully used as therapeutic reagents for humans after humanization by genetic engineering. However, utilization of these antibodies for therapeutic purpose has been limited by the fact that they act as immunogens in human body causing undesired side effects. So far, there have been several attempts to produce human mAbs for effective in vivo diagnostic or therapeutic reagents including the use of humanized xenomouse that is generated by mating knockout mice which lost Ig heavy and light chain genes by homologous recombination and transgenic mice having both human Ig heavy and light gene loci in their genome. METHODS: Genomic DNA fragments of mouse Ig heavy and light chain were obtained from a mouse brain lamda genomic library by PCR screening and cloned into a targeting vector with ultimate goal of generating Ig knockout mouse. RESULTS: Through PCR screening of the genomic library, three heavy chain and three light chain Ig gene fragments were identified, and restriction map of one of the heavy chain gene fragments was determined. Then heavy chain Ig gene fragments were subcloned into a targeting vector. The resulting construct was introduced into embryonic stem cells. Antibiotic selection of transfected cells is under the progress. CONCLUSION: Generation of xenomouse is particularly important in medical biotechnology. However, this goal is not easily achieved due to the technical difficulties as well as huge financial expenses. Although we are in the early stage of a long-term project, our results, at least, partially contribute the successful generation of humanized xenomouse in Korea.
